STOCK TITAN

Inflection Point Acquisition IV Stock Price, News & Analysis

BACQU NASDAQ

Company Description

Inflection Point Acquisition Corp. IV (NASDAQ: BACQU), referenced in SEC filings and news as Bleichroeder Acquisition Corp. I and Inflection Point Acquisition Corp. IV, is a special purpose acquisition company (SPAC) categorized as a shell company in the financial services sector. According to company disclosures, it was formed as a blank check company for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

The company’s units trade on the Nasdaq under the symbol BACQU. Each unit consists of one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share upon the consummation of the company’s initial business combination, as described in its IPO announcements. The Class A ordinary shares and rights are expected to trade separately under the symbols BACQ and BACQR, respectively, once they begin separate trading.

Business purpose and SPAC structure

Inflection Point Acquisition Corp. IV’s stated mandate is to pursue a business combination with one or more businesses. The company has disclosed that it may pursue an acquisition opportunity in any business or industry, with a primary focus on businesses in the technology, media and telecommunications (TMT) sector as well as sectors that are being transformed via technology adoption. As a blank check company, it does not have commercial operations of its own; instead, its business model centers on identifying, negotiating, and completing a qualifying transaction.

Proceeds from its initial public offering and a simultaneous private placement were placed in a trust account, as described in its IPO press releases. These funds are intended to be used to complete the initial business combination, subject to shareholder approvals and other customary conditions. Investors in BACQU units therefore gain exposure to the future combined company that may result from a merger or similar transaction.

Proposed business combination with Merlin Labs

SEC filings report that Bleichroeder Acquisition Corp. I, which will be renamed Inflection Point Acquisition Corp. IV and is associated with the BACQ/BACQR listings, entered into a Business Combination Agreement with Merlin Labs, Inc., a developer of assured, autonomous flight technology for defense customers. Under this agreement, a wholly owned merger subsidiary of Inflection Point will merge with and into Merlin Labs, with Merlin Labs continuing as the surviving company and becoming a wholly owned subsidiary of Inflection Point.

In connection with the closing of the business combination, Inflection Point will domesticate from the Cayman Islands to Delaware and change its name to Merlin Labs, Inc., with the combined company referred to in filings as “New Merlin Labs.” The transaction structure described in the Business Combination Agreement includes the conversion of Merlin Labs preferred stock into common stock, the treatment of options and restricted stock units, and the issuance of New Merlin Labs common stock and preferred stock as consideration. The aggregate consideration to Merlin Labs securityholders is based on a stated equity value and the redemption price of Inflection Point’s Class A shares, as detailed in the filing.

Capital raising and PIPE commitments

News releases describe Inflection Point’s role in arranging a private investment in public equity (PIPE) to support the proposed combination with Merlin Labs. The parties disclosed that PIPE commitments were increased to more than $200 million, including over $85 million of pre-funded PIPE capital, compared to more than $125 million at the signing of the Business Combination Agreement. Filings also note that Inflection Point and Merlin Labs are contemplating raising additional funds in private placement transactions exempt from registration to support a strategic partnership between Merlin Labs and GE Aerospace, with such private placements conditioned on the consummation of the business combination.

Strategic focus and target sectors

While Inflection Point Acquisition Corp. IV may pursue an acquisition in any sector, its IPO disclosures state a primary focus on TMT and sectors undergoing transformation through technology adoption. The proposed transaction with Merlin Labs, which develops AI-powered autonomous flight technology for defense and civil aviation programs, aligns with this focus on technology-driven businesses. Public communications describe Merlin Labs as a leading U.S.-based developer of cost-effective, takeoff-to-touchdown autonomy for legacy and next-generation airborne systems, with aircraft-agnostic, AI-powered software and contracts from military customers.

Corporate status and regulatory context

Inflection Point Acquisition Corp. IV is identified in SEC filings as an emerging growth company. Its Class A ordinary shares and rights are listed on the Nasdaq Stock Market. The company has filed a current report on Form 8-K describing the Business Combination Agreement with Merlin Labs and the planned domestication to Delaware. Additional filings discuss governance arrangements for the post-combination board of directors, the treatment of existing securities, and the mechanics of the merger.

Communications related to the business combination emphasize that a registration statement on Form S-4 (or similar registration statement) will be filed with the SEC, including a proxy statement/prospectus to be distributed to Inflection Point shareholders. Investors and securityholders are advised in those communications to read the registration statement, proxy statement/prospectus, and other relevant documents when available, as they will contain important information about the business combination and the parties involved.

Management and advisory relationships

Company disclosures describe management and board changes as the SPAC pursued its business combination. An 8-K filing reports that certain executives resigned and new officers, including a President and Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer, were appointed. The filing notes that some of these officers are affiliates of Inflection Point Asset Management and Inflection Point Fund I LP, which are associated with the broader Inflection Point SPAC franchise.

Another 8-K describes a consulting agreement with MJP Advisory Group LLC under which the consultant will provide financial, due diligence, valuation, and other advisory services to the company in connection with its pursuit of a business combination. The agreement includes a retainer fee upon execution of a definitive agreement for a business combination and a monthly services fee for the term of the engagement.

Investor considerations

As a SPAC, Inflection Point Acquisition Corp. IV’s value proposition to investors is tied to its ability to complete a business combination and the subsequent performance of the combined company. Company and Merlin Labs communications highlight that the business combination will be submitted to Inflection Point shareholders for approval, and that shareholders will have the opportunity to vote on the transaction and, under typical SPAC structures, to exercise redemption rights with respect to their shares.

Forward-looking statements in news releases and SEC filings emphasize that actual results and events may differ materially from expectations due to a variety of risks and uncertainties, including the ability to consummate the business combination, the level of shareholder redemptions, the success of capital raising efforts, competition, and the ability of the combined company to execute its strategy and maintain an exchange listing. These communications also clarify that they do not constitute offers to sell or solicitations of offers to buy securities, and that any such offers will be made only by means of a prospectus that meets applicable regulatory requirements.

Stock Performance

$—
0.00%
0.00
Last updated:
+10.34%
Performance 1 year

Financial Highlights

Revenue (TTM)
Net Income (TTM)
Operating Cash Flow

Upcoming Events

Short Interest History

Last 12 Months
Loading short interest data...

Short interest in Inflection Point Acquisition IV (BACQU) currently stands at 111 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 97.1%. This relatively low short interest suggests limited bearish sentiment.

Days to Cover History

Last 12 Months
Loading days to cover data...

Days to cover for Inflection Point Acquisition IV (BACQU) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.

Frequently Asked Questions

What is the current stock price of Inflection Point Acquisition IV (BACQU)?

The current stock price of Inflection Point Acquisition IV (BACQU) is $11.2 as of February 27, 2026.

What is Inflection Point Acquisition Corp. IV (BACQU)?

Inflection Point Acquisition Corp. IV, associated in filings with Bleichroeder Acquisition Corp. I, is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It is categorized as a shell company in the financial services sector.

How does Inflection Point Acquisition Corp. IV generate value for investors?

As a SPAC, Inflection Point Acquisition Corp. IV does not operate an ongoing business. Instead, it raises capital in an initial public offering and places the proceeds in a trust account, with the intention of using those funds to complete an initial business combination. Investor outcomes depend on the terms and success of that transaction and any subsequent combined company.

What sectors does Inflection Point Acquisition Corp. IV target for a business combination?

Company disclosures state that Inflection Point Acquisition Corp. IV may pursue an acquisition opportunity in any business or industry, with a primary focus on businesses in the technology, media and telecommunications (TMT) sector and sectors being transformed via technology adoption.

What is the relationship between Inflection Point Acquisition Corp. IV and Merlin Labs, Inc.?

According to SEC filings, Bleichroeder Acquisition Corp. I, which will be renamed Inflection Point Acquisition Corp. IV, entered into a Business Combination Agreement with Merlin Labs, Inc. A merger subsidiary of Inflection Point will merge with and into Merlin Labs, with Merlin Labs becoming a wholly owned subsidiary and the combined company expected to be named Merlin Labs, Inc., subject to shareholder approvals and closing conditions.

What happens to BACQU units, shares, and rights in the SPAC structure?

IPO disclosures state that each BACQU unit consists of one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share upon the consummation of the initial business combination. Once separate trading begins, the Class A ordinary shares and rights are expected to trade under the symbols BACQ and BACQR, respectively, with rights converting into fractional shares as described in the company’s agreements.

What stock exchange lists Inflection Point Acquisition Corp. IV securities?

Press releases and SEC filings indicate that the company’s units are listed on the Nasdaq Global Market under the ticker symbol BACQU. The Class A ordinary shares and rights are expected to be listed on Nasdaq under the symbols BACQ and BACQR, respectively, once they begin separate trading.

What capital has been raised to support the proposed Merlin Labs transaction?

News reports state that Inflection Point and investors increased PIPE commitments to more than $200 million in connection with the proposed business combination with Merlin Labs, including over $85 million of pre-funded PIPE capital. SEC filings also note that additional private placement transactions are being contemplated to support a strategic partnership involving Merlin Labs and GE Aerospace, conditioned on closing the business combination.

Is the business combination between Inflection Point Acquisition Corp. IV and Merlin Labs guaranteed to close?

No. Forward-looking statements in news releases and SEC filings emphasize that the business combination is subject to various conditions, including shareholder approvals, regulatory processes, financing, and other customary closing conditions. They note that actual events may differ materially from expectations and that the transaction may not be consummated.

How will Inflection Point Acquisition Corp. IV change after the business combination?

SEC filings describe that, in connection with the closing of the business combination, Inflection Point will domesticate from the Cayman Islands to Delaware and change its name to Merlin Labs, Inc. The combined company is referred to as New Merlin Labs in the filings, and its board of directors will be reconstituted with individuals designated by both Inflection Point and Merlin Labs.

Where can investors find official information about Inflection Point Acquisition Corp. IV and its merger plans?

Company communications state that Inflection Point intends to file a registration statement with the SEC that will include a proxy statement/prospectus for shareholders. Investors and securityholders are advised in those communications to read the registration statement, proxy statement/prospectus, and other relevant documents filed with the SEC when they become available, as they will contain important information about the business combination and the parties involved.